Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 28, 2011 - Issue 4
Submit an article Journal homepage
103
Views
0
CrossRef citations to date
0
Altmetric
COMMENTARY

Pediatric Acute Myeloid Leukemia—is There a Scope for Change in the Developing World?

Sangeeta MudaliarDepartment of Pediatric Hematology and Oncology, B. J. Wadia Hospital for Children, Institute for Child Health and Research Centre, Parel, Mumbai, India
&
Bharat AgarwalDepartment of Pediatric Hematology and Oncology, B. J. Wadia Hospital for Children, Institute for Child Health and Research Centre, Parel, Mumbai, IndiaCorrespondence[email protected]
Pages 253-256 | Published online: 27 Apr 2011

REFERENCES

  • Weinstein HJ. Acute myeloid leukaemia. In: Pui CH, ed. Childhood Leukaemias. Cambridge, UK: Cambridge University Press; 1999:322–335.
  • Ghosh S, Shinde SC, Kumaran GS, Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital. Indian J Cancer. 2003;40:71–76.
  • Bhatia S, Negra JP. Epidemiology of childhood acute myelogenous leukaemia. J Pediatr Oncol. 1995;17:94–100.
  • Woods WG, Kobrinsky N, Buckley JD, Timed-sequential induction therapy improves postremission utcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood. 1996;87:4979–4989.
  • Stevens RF, Hann IM, Wheatley K, Gray RG. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. Br J Haematol. 1998;101:130– 140.
  • Lehrnbecher T, Varwig D, Kaiser J, Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia. 2004;18:72–77.
  • Perel Y, Auvrignon A, Leblanc T, Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucamie Aique Myeloide Enfant. J Clin Oncol. 2002;20:2774–2782.
  • Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood. 2005;106:1154–1163.
  • Sanz MA, Martin G, Gonzalez M, Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Blood. 2004;103:1237–1243.
  • Sanz MA, Tallman MS, Lo-Coco F. Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood. 2005;105:3019–3025.
  • Redaniel MT, Laudico A, Mirasol-Lumague MR, Cancer survival discrepancies in developed and developing countries: comparisons between the Philippines and the United States. Br J Cancer. 2009;100:858–862.
  • Monge P, Wesseling C, Rodriguez AC, Childhood leukaemia in Costa Rica, 1981–96. Paediatr Perinat Epidemiol. 2002;16:210–218.
  • Mejia-Arangure JM, Fajardo-Gutierrez A, Bernaldez-Rios R, Incidence trends of acute leukemia among the children of Mexico City: 1982–1991. Arch Med Res. 1996;27:223–227.
  • Fajardo-Gutierrez A, Navarrete-Martinez A, Reynoso-Garcia M, Incidence of malignant neoplasms in children attending Social Security Hospitals in Mexico City. Med Pediatr Oncol. 1997;29:208–212.
  • Mejia-Arangure JM, Fajardo-Gutierrez A, Bernaldez-Rios R, Incidence of acute leukemia in children in Mexico City, from 1982 to 1991. Salud Publica Mex. 2000;42:431–437.
  • Usmani GN. Pediatric oncology in the third world. Curr Opin Pediatr. 2001;13:1–9.
  • Pulcheri W, Spector N, Nucci M, The treatment of acute myeloid leukemia in Brazil: progress and obstacles. Haematologica. 1995;80:130–135.
  • Sanz MA, Lo CF. Standard practice and controversial issues in front-line therapy of acute promyelocytic leukemia. Haematologica. 2005;90:840–845.
  • Ribeiro RC, Rego E. American Society of Hematology: management of APL in developing countries: epidemiology, challenges and opportunities for international collaboration. Hematology. 2006;1:162–168.
  • Grimwad D, Walker H, Oliver F, Medical Research Council Adult and Children's Leukaemia Working Parties. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood. 1998;92:2322–2333.
  • Pui CH, Ribeiro RC. International collaboration on childhood leukemia. Int J Hematol. 2003;78:383–389.
  • Agarwal BR, Dalvi RB. Treatment of childhood leukemias in underprivileged countries. In: Pui CH, ed. Treatment of Acute Leukemias: New Directions for Clinical Research. Current Clinical Oncology Series. Totowa, NJ: Humana Press; 2003:321–329.
  • Barr RD, Ribeiro RC, Agarwal BR et al. Pediatric oncology in countries with limited resources. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2002:1541–1552.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.